Steve Cohen: portfolio of Point72 Asset Management
Steve Cohen leads Point72, the successor to SAC Capital; the portfolio holds a very large number of positions and changes often.
Source: 13F filing with the US Securities and Exchange Commission dated Feb 14, 2025. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q4 2024. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 35.7B USD
- Positions
- 1,190
- Share of the ten largest
- 13.3%
The ten largest positions Q4 2024
- Amazon 2.6%new
- Microsoft 2.0%▲ +356.9%
- Nvidia 1.6%▲ +13.5%
- Taiwan Semiconductor Manufacturing (ADR) 1.4%▲ +106.7%
- Coca-Cola Company (The) 1.0%▲ +450.3%
- AT&T 1.0%new
- Intuit 1.0%▲ +2,450.4%
- Walt Disney Company (The) 1.0%new
- Arista Networks 0.9%▼ −14.0%
- Adobe Inc. 0.9%▲ +180.7%
Show all positions of this quarter
Choose a quarter (50 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
All positions Q4 2024
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| ANET Arista Networks | 0.9% | 3,021,154 | 333.9M USD | −14.0% reducedafter 4:1 stock split | Q1 2021 16 quarters |
| Macom Tech Solutions HLDGS I | 0.7% | 1,972,454 | 256.2M USD | −22.8% reduced | Q1 2024 4 quarters |
| LITE Lumentum | 0.7% | 2,952,790 | 247.9M USD | −26.0% reduced | Q3 2023 6 quarters |
| CRDO Credo Technology Group | 0.6% | 3,084,621 | 207.3M USD | −21.2% reduced | Q1 2022 12 quarters |
| BSX Boston Scientific | 0.6% | 2,245,799 | 200.6M USD | −33.6% reduced | Q3 2021 14 quarters |
| EQT EQT Corporation | 0.5% | 4,027,267 | 185.7M USD | −17.8% reduced | Q2 2024 3 quarters |
| ISRG Intuitive Surgical | 0.5% | 338,696 | 176.8M USD | −22.6% reduced | Q4 2022 9 quarters |
| Spotify Technology S A | 0.4% | 349,355 | 156.3M USD | −3.2% reduced | Q2 2024 3 quarters |
| Bath & Body Works Inc | 0.4% | 3,873,396 | 150.2M USD | −22.8% reduced | Q3 2021 14 quarters |
| COHR Coherent Corp. | 0.4% | 1,560,646 | 147.8M USD | −33.5% reduced | Q2 2023 7 quarters |
| EVRG Evergy | 0.4% | 2,338,687 | 143.9M USD | −17.9% reduced | Q2 2023 7 quarters |
| Flutter Entmt PLC | 0.4% | 554,684 | 143.4M USD | −5.0% reduced | Q2 2024 3 quarters |
| IP International Paper | 0.4% | 2,506,214 | 134.9M USD | −15.6% reduced | Q2 2023 7 quarters |
| JD JD.com (ADR) | 0.4% | 3,764,100 | 130.5M USD | −6.7% reduced | Q3 2023 6 quarters |
| MMM 3M | 0.4% | 979,572 | 126.5M USD | −2.7% reduced | Q3 2023 6 quarters |
| Bellring Brands Inc | 0.3% | 1,537,883 | 115.9M USD | −40.6% reduced | Q1 2022 12 quarters |
| Mastec Inc | 0.3% | 734,211 | 100.0M USD | −3.9% reduced | Q3 2022 10 quarters |
| INCY Incyte | 0.2% | 1,278,369 | 88.3M USD | −46.0% reduced | Q3 2024 2 quarters |
| WFC Wells Fargo | 0.2% | 1,216,078 | 85.4M USD | −15.0% reduced | Q2 2024 3 quarters |
| GLW Corning Inc. | 0.2% | 1,790,833 | 85.1M USD | −2.8% reduced | Q3 2024 2 quarters |
| APTV Aptiv | 0.2% | 1,379,160 | 83.4M USD | −31.0% reduced | Q3 2024 2 quarters |
| Bio Rad Labs Inc | 0.2% | 247,510 | 81.3M USD | −1.0% reduced | Q3 2024 2 quarters |
| APH Amphenol | 0.2% | 1,150,490 | 79.9M USD | −48.0% reduced | Q1 2024 4 quarters |
| BMY Bristol Myers Squibb | 0.2% | 1,410,278 | 79.8M USD | −51.0% reduced | Q1 2024 4 quarters |
| GILD Gilead Sciences | 0.2% | 856,657 | 79.1M USD | −62.8% reduced | Q1 2024 4 quarters |
| Liberty Media Corp Del | 0.2% | 1,164,693 | 77.5M USD | −26.0% reduced | Q3 2023 6 quarters |
| Dynatrace Inc | 0.2% | 1,425,361 | 77.5M USD | −45.1% reduced | Q3 2023 6 quarters |
| CMCSA Comcast | 0.2% | 2,041,705 | 76.6M USD | −72.9% reduced | Q2 2024 3 quarters |
| XYZ Block, Inc. | 0.2% | 850,846 | 72.3M USD | −43.6% reduced | Q2 2024 3 quarters |
| Canadian Natl Ry Co | 0.2% | 694,030 | 70.5M USD | −49.2% reduced | Q3 2024 2 quarters |
| Chord Energy Corporation | 0.2% | 595,899 | 69.7M USD | −32.3% reduced | Q1 2024 4 quarters |
| COF Capital One | 0.2% | 381,730 | 68.1M USD | −37.6% reduced | Q1 2023 8 quarters |
| Webster Finl Corp | 0.2% | 1,222,758 | 67.5M USD | −11.8% reduced | Q1 2022 12 quarters |
| Skechers U S A Inc | 0.2% | 975,797 | 65.6M USD | −58.6% reduced | Q1 2023 8 quarters |
| TEAM Atlassian | 0.2% | 265,112 | 64.5M USD | −62.1% reduced | Q2 2024 3 quarters |
| MKC McCormick & Company | 0.2% | 797,003 | 60.8M USD | −48.4% reduced | Q2 2024 3 quarters |
| Qorvo Inc | 0.2% | 865,162 | 60.5M USD | −9.5% reduced | Q4 2022 9 quarters |
| RAPID7 Inc | 0.2% | 1,485,477 | 59.8M USD | −54.2% reduced | Q1 2023 8 quarters |
| Acadia Healthcare Company In | 0.2% | 1,474,220 | 58.5M USD | −35.4% reduced | Q4 2023 5 quarters |
| Ambarella Inc | 0.2% | 802,280 | 58.4M USD | −6.9% reduced | Q3 2021 14 quarters |
| Ishares TR | 0.2% | 1,125,000 | 58.2M USD | −1.7% reduced | Q4 2023 5 quarters |
| META Meta Platforms | 0.2% | 91,769 | 53.7M USD | −26.0% reduced | Q3 2024 2 quarters |
| UAL United Airlines Holdings | 0.1% | 551,933 | 53.6M USD | −64.9% reduced | Q3 2022 10 quarters |
| Madison Square Garden Entmt | 0.1% | 1,442,640 | 51.4M USD | −5.6% reduced | Q2 2023 7 quarters |
| Cognex Corp | 0.1% | 1,427,826 | 51.2M USD | −49.6% reduced | Q3 2023 6 quarters |
| Talen Energy Corp | 0.1% | 253,592 | 51.1M USD | −46.8% reduced | Q3 2024 2 quarters |
| Xencor Inc | 0.1% | 2,177,081 | 50.0M USD | −30.2% reduced | Q1 2024 4 quarters |
| Borgwarner Inc | 0.1% | 1,569,861 | 49.9M USD | −26.1% reduced | Q4 2023 5 quarters |
| Lithia Mtrs Inc | 0.1% | 137,269 | 49.1M USD | −39.9% reduced | Q3 2023 6 quarters |
| Natera Inc | 0.1% | 305,243 | 48.3M USD | −56.2% reduced | Q3 2023 6 quarters |
| Wendys Co | 0.1% | 2,959,439 | 48.2M USD | −54.1% reduced | Q2 2024 3 quarters |
| Gfl Environmental Inc | 0.1% | 1,082,574 | 48.2M USD | −12.3% reduced | Q2 2023 7 quarters |
| Lpl Finl HLDGS Inc | 0.1% | 147,089 | 48.0M USD | −58.0% reduced | Q2 2024 3 quarters |
| Livanova PLC | 0.1% | 1,036,248 | 48.0M USD | −50.5% reduced | Q1 2023 8 quarters |
| Shake Shack Inc | 0.1% | 357,760 | 46.4M USD | −45.0% reduced | Q2 2023 7 quarters |
| TRV Travelers Companies (The) | 0.1% | 190,460 | 45.9M USD | −18.9% reduced | Q3 2024 2 quarters |
| GPN Global Payments | 0.1% | 408,817 | 45.8M USD | −73.5% reduced | Q2 2024 3 quarters |
| Glaukos Corp | 0.1% | 280,312 | 42.0M USD | −26.9% reduced | Q2 2024 3 quarters |
| Cogent Biosciences Inc | 0.1% | 5,347,302 | 41.7M USD | −48.9% reduced | Q1 2023 8 quarters |
| JCI Johnson Controls | 0.1% | 513,449 | 40.5M USD | −58.6% reduced | Q1 2023 8 quarters |
| Praxis Precision Medicines I | 0.1% | 521,273 | 40.1M USD | −49.5% reduced | Q4 2023 5 quarters |
| Madison Square Grdn Sprt Cor | 0.1% | 167,864 | 37.9M USD | −30.5% reduced | Q4 2023 5 quarters |
| Five Below Inc | 0.1% | 350,576 | 36.8M USD | −23.0% reduced | Q4 2023 5 quarters |
| IVZ Invesco | < 0.1% | 2,041,010 | 35.7M USD | −36.5% reduced | Q2 2024 3 quarters |
| BKR Baker Hughes | < 0.1% | 862,306 | 35.4M USD | −65.2% reduced | Q2 2024 3 quarters |
| Biohaven Ltd | < 0.1% | 922,965 | 34.5M USD | −38.5% reduced | Q3 2022 10 quarters |
| Select Med HLDGS Corp | < 0.1% | 1,743,085 | 32.9M USD | −15.4% reduced | Q1 2024 4 quarters |
| WY Weyerhaeuser | < 0.1% | 1,152,534 | 32.4M USD | −4.3% reduced | Q3 2024 2 quarters |
| Shoals Technologies Group In | < 0.1% | 5,537,579 | 30.6M USD | −19.1% reduced | Q3 2023 6 quarters |
| FFIV F5, Inc. | < 0.1% | 121,105 | 30.5M USD | −24.0% reduced | Q3 2024 2 quarters |
| CSGP CoStar Group | < 0.1% | 417,487 | 29.9M USD | −35.4% reduced | Q3 2024 2 quarters |
| LNT Alliant Energy | < 0.1% | 504,451 | 29.8M USD | −68.6% reduced | Q2 2024 3 quarters |
| Arcus Biosciences Inc | < 0.1% | 1,996,279 | 29.7M USD | −18.1% reduced | Q2 2023 7 quarters |
| Rogers Communications Inc | < 0.1% | 937,328 | 28.8M USD | −72.5% reduced | Q3 2022 10 quarters |
| D Dominion Energy | < 0.1% | 522,660 | 28.2M USD | −76.8% reduced | Q4 2023 5 quarters |
| VEEV Veeva Systems | < 0.1% | 129,305 | 27.2M USD | −46.4% reduced | Q3 2024 2 quarters |
| Reinsurance Grp Of America I | < 0.1% | 125,812 | 26.9M USD | −32.8% reduced | Q1 2023 8 quarters |
| Discover Finl Svcs | < 0.1% | 155,132 | 26.9M USD | −48.3% reduced | Q3 2022 10 quarters |
| Navitas Semiconductor Corp | < 0.1% | 7,298,195 | 26.1M USD | −9.1% reduced | Q4 2023 5 quarters |
| Syndax Pharmaceuticals Inc | < 0.1% | 1,915,736 | 25.3M USD | −31.0% reduced | Q4 2022 9 quarters |
| Akero Therapeutics Inc | < 0.1% | 899,680 | 25.0M USD | −31.0% reduced | Q3 2024 2 quarters |
| WAB Wabtec | < 0.1% | 131,700 | 25.0M USD | −24.3% reduced | Q1 2023 8 quarters |
| Shell PLC | < 0.1% | 374,843 | 23.5M USD | −93.2% reduced | Q4 2023 5 quarters |
| Restaurant Brands Intl Inc | < 0.1% | 352,067 | 22.9M USD | −76.0% reduced | Q2 2024 3 quarters |
| Matador Res Co | < 0.1% | 406,049 | 22.8M USD | −60.6% reduced | Q3 2024 2 quarters |
| Lenz Therapeutics Inc | < 0.1% | 783,921 | 22.6M USD | −9.4% reduced | Q1 2024 4 quarters |
| DASH DoorDash | < 0.1% | 132,119 | 22.2M USD | −76.7% reduced | Q3 2023 6 quarters |
| CIEN Ciena | < 0.1% | 254,810 | 21.6M USD | −72.9% reduced | Q3 2024 2 quarters |
| Olema Pharmaceuticals Inc | < 0.1% | 3,670,826 | 21.4M USD | −0.4% reduced | Q2 2024 3 quarters |
| Vaxcyte Inc | < 0.1% | 251,055 | 20.6M USD | −30.2% reduced | Q3 2024 2 quarters |
| APA APA Corporation | < 0.1% | 880,112 | 20.3M USD | −51.7% reduced | Q2 2024 3 quarters |
| Anheuser Busch Inbev Sa/Nv | < 0.1% | 394,267 | 19.7M USD | −58.9% reduced | Q3 2024 2 quarters |
| Griffon Corp | < 0.1% | 272,065 | 19.4M USD | −42.5% reduced | Q1 2023 8 quarters |
| Old Rep Intl Corp | < 0.1% | 516,053 | 18.7M USD | −15.4% reduced | Q2 2024 3 quarters |
| Grocery Outlet Hldg Corp | < 0.1% | 1,162,468 | 18.1M USD | −5.9% reduced | Q4 2023 5 quarters |
| Kinetik Holdings Inc | < 0.1% | 309,037 | 17.5M USD | −12.3% reduced | Q1 2024 4 quarters |
| California Res Corp | < 0.1% | 327,208 | 17.0M USD | −54.3% reduced | Q2 2023 7 quarters |
| Acushnet HLDGS Corp | < 0.1% | 235,844 | 16.8M USD | −11.4% reduced | Q2 2023 7 quarters |
| Rubrik Inc. | < 0.1% | 253,774 | 16.6M USD | −80.7% reduced | Q3 2024 2 quarters |
| COO Cooper Companies (The) | < 0.1% | 179,139 | 16.5M USD | −5.0% reduced | Q1 2022 12 quarters |
| HOOD Robinhood Markets | < 0.1% | 436,353 | 16.3M USD | −71.8% reduced | Q3 2023 6 quarters |
| Corvus Pharmaceuticals Inc | < 0.1% | 3,030,011 | 16.2M USD | −45.5% reduced | Q2 2024 3 quarters |
| Triumph Group Inc New | < 0.1% | 866,936 | 16.2M USD | −22.0% reduced | Q2 2021 15 quarters |
| ALGN Align Technology | < 0.1% | 76,364 | 15.9M USD | −88.7% reduced | Q3 2023 6 quarters |
| Axsome Therapeutics Inc | < 0.1% | 185,138 | 15.7M USD | −65.9% reduced | Q2 2022 11 quarters |
| GOOG Alphabet Inc. (Class C) | < 0.1% | 80,361 | 15.3M USD | −65.5% reduced | Q3 2024 2 quarters |
| Patterson-Uti Energy Inc | < 0.1% | 1,844,659 | 15.2M USD | −45.9% reduced | Q1 2023 8 quarters |
| Crown HLDGS Inc | < 0.1% | 182,822 | 15.1M USD | −51.5% reduced | Q4 2022 9 quarters |
| VMC Vulcan Materials Company | < 0.1% | 55,989 | 14.4M USD | −47.1% reduced | Q1 2021 16 quarters |
| Apogee Therapeutics Inc | < 0.1% | 302,735 | 13.7M USD | −57.2% reduced | Q3 2023 6 quarters |
| Vale S A | < 0.1% | 1,545,218 | 13.7M USD | −59.1% reduced | Q4 2023 5 quarters |
| Rxsight Inc | < 0.1% | 391,732 | 13.5M USD | −12.4% reduced | Q3 2022 10 quarters |
| Corebridge Finl Inc | < 0.1% | 438,460 | 13.1M USD | −21.4% reduced | Q4 2023 5 quarters |
| Joyy Inc | < 0.1% | 312,927 | 13.1M USD | −12.6% reduced | Q2 2022 11 quarters |
| Topbuild Corp | < 0.1% | 41,546 | 12.9M USD | −54.4% reduced | Q1 2023 8 quarters |
| Structure Therapeutics Inc | < 0.1% | 476,698 | 12.9M USD | −61.5% reduced | Q2 2024 3 quarters |
| Parsons Corp Del | < 0.1% | 139,940 | 12.9M USD | −39.6% reduced | Q3 2023 6 quarters |
| Heico Corp New | < 0.1% | 69,203 | 12.9M USD | −3.8% reduced | Q1 2023 8 quarters |
| FERG Ferguson Enterprises | < 0.1% | 73,917 | 12.8M USD | −76.1% reduced | Q3 2024 2 quarters |
| Telephone & Data Sys Inc | < 0.1% | 373,175 | 12.7M USD | −20.6% reduced | Q2 2024 3 quarters |
| Grand Canyon Ed Inc | < 0.1% | 72,880 | 11.9M USD | −34.2% reduced | Q1 2024 4 quarters |
| FTV Fortive | < 0.1% | 158,896 | 11.9M USD | −91.8% reduced | Q1 2024 4 quarters |
| Gibraltar Inds Inc | < 0.1% | 190,588 | 11.2M USD | −9.3% reduced | Q3 2022 10 quarters |
| Clearway Energy Inc | < 0.1% | 429,637 | 11.2M USD | −49.0% reduced | Q4 2023 5 quarters |
| Dutch Bros Inc | < 0.1% | 213,249 | 11.2M USD | −72.8% reduced | Q4 2023 5 quarters |
| Yeti HLDGS Inc | < 0.1% | 280,534 | 10.8M USD | −63.3% reduced | Q2 2024 3 quarters |
| HAS Hasbro | < 0.1% | 193,171 | 10.8M USD | −75.1% reduced | Q4 2022 9 quarters |
| Canadian Nat Res Ltd | < 0.1% | 347,904 | 10.7M USD | −84.5% reduced | Q1 2024 4 quarters |
| Gulfport Energy Corp | < 0.1% | 56,930 | 10.5M USD | −71.1% reduced | Q2 2023 7 quarters |
| Sagimet Biosciences Inc | < 0.1% | 2,316,572 | 10.4M USD | −3.2% reduced | Q1 2024 4 quarters |
| DD DuPont | < 0.1% | 136,605 | 10.4M USD | −52.0% reduced | Q2 2019 23 quarters |
| Jazz Pharmaceuticals PLC | < 0.1% | 84,151 | 10.4M USD | −68.7% reduced | Q2 2024 3 quarters |
| Lendingclub Corp | < 0.1% | 637,932 | 10.3M USD | −58.8% reduced | Q3 2023 6 quarters |
| Manpowergroup Inc Wis | < 0.1% | 177,320 | 10.2M USD | −45.4% reduced | Q2 2024 3 quarters |
| Brinker Intl Inc | < 0.1% | 74,314 | 9.8M USD | −68.1% reduced | Q3 2024 2 quarters |
| Essential Utils Inc | < 0.1% | 258,013 | 9.4M USD | −67.7% reduced | Q3 2024 2 quarters |
| Progyny Inc | < 0.1% | 534,074 | 9.2M USD | −32.3% reduced | Q1 2024 4 quarters |
| Copa Holdings SA | < 0.1% | 103,701 | 9.1M USD | −31.0% reduced | Q3 2024 2 quarters |
| Zeekr Intelligent Technology | < 0.1% | 318,192 | 9.0M USD | −52.0% reduced | Q2 2024 3 quarters |
| Cg Oncology Inc | < 0.1% | 308,259 | 8.8M USD | −58.7% reduced | Q1 2024 4 quarters |
| Yelp Inc | < 0.1% | 221,769 | 8.6M USD | −50.4% reduced | Q1 2024 4 quarters |
| PH Parker Hannifin | < 0.1% | 13,082 | 8.3M USD | −91.7% reduced | Q3 2024 2 quarters |
| Synaptics Inc | < 0.1% | 107,332 | 8.2M USD | −47.1% reduced | Q1 2024 4 quarters |
| Chewy Inc | < 0.1% | 244,181 | 8.2M USD | −78.9% reduced | Q3 2024 2 quarters |
| Amer Sports Inc | < 0.1% | 290,274 | 8.1M USD | −88.6% reduced | Q1 2024 4 quarters |
| DLR Digital Realty | < 0.1% | 45,140 | 8.0M USD | −94.5% reduced | Q3 2024 2 quarters |
| Cytokinetics Inc | < 0.1% | 169,913 | 8.0M USD | −63.4% reduced | Q4 2023 5 quarters |
| WELL Welltower | < 0.1% | 63,059 | 7.9M USD | −39.1% reduced | Q2 2024 3 quarters |
| Tenaris S A | < 0.1% | 207,961 | 7.9M USD | −80.2% reduced | Q1 2024 4 quarters |
| AEE Ameren | < 0.1% | 88,000 | 7.8M USD | −49.2% reduced | Q3 2024 2 quarters |
| Silicon Laboratories Inc | < 0.1% | 63,001 | 7.8M USD | −1.7% reduced | Q3 2024 2 quarters |
| Goodyear Tire & Rubr Co | < 0.1% | 850,798 | 7.7M USD | −17.4% reduced | Q2 2024 3 quarters |
| Caesars Entertainment Inc Ne | < 0.1% | 226,696 | 7.6M USD | −64.6% reduced | Q3 2024 2 quarters |
| American Woodmark Corporatio | < 0.1% | 94,900 | 7.5M USD | −44.5% reduced | Q3 2024 2 quarters |
| Hewlett Packard Enterprise C | < 0.1% | 117,011 | 7.3M USD | −17.5% reduced | Q3 2024 2 quarters |
| Crane Company | < 0.1% | 46,500 | 7.1M USD | −56.9% reduced | Q3 2024 2 quarters |
| Oruka Therapeutics Inc | < 0.1% | 360,732 | 7.0M USD | −25.2% reduced | Q3 2024 2 quarters |
| Terns Pharmaceuticals Inc | < 0.1% | 1,251,841 | 6.9M USD | −53.8% reduced | Q1 2024 4 quarters |
| AXON Axon Enterprise | < 0.1% | 11,154 | 6.6M USD | −86.0% reduced | Q3 2024 2 quarters |
| Royalty Pharma PLC | < 0.1% | 249,003 | 6.4M USD | −52.7% reduced | Q3 2024 2 quarters |
| VLO Valero Energy | < 0.1% | 49,669 | 6.1M USD | −95.1% reduced | Q3 2024 2 quarters |
| Celestica Inc | < 0.1% | 64,070 | 5.9M USD | −94.1% reduced | Q2 2024 3 quarters |
| Alphatec HLDGS Inc | < 0.1% | 598,003 | 5.5M USD | −30.5% reduced | Q4 2020 17 quarters |
| Astera Labs Inc | < 0.1% | 40,000 | 5.3M USD | −81.7% reduced | Q3 2024 2 quarters |
| ROK Rockwell Automation | < 0.1% | 17,906 | 5.1M USD | −46.0% reduced | Q3 2024 2 quarters |
| Sterling Infrastructure Inc | < 0.1% | 29,695 | 5.0M USD | −76.2% reduced | Q3 2022 10 quarters |
| Genedx Holdings Corp | < 0.1% | 63,088 | 4.8M USD | −78.5% reduced | Q1 2024 4 quarters |
| Myriad Genetics Inc | < 0.1% | 348,604 | 4.8M USD | −67.2% reduced | Q1 2024 4 quarters |
| Beigene Ltd | < 0.1% | 25,166 | 4.6M USD | −96.2% reduced | Q2 2024 3 quarters |
| Select Sector SPDR TR | < 0.1% | 35,044 | 4.6M USD | −40.4% reduced | Q2 2024 3 quarters |
| Blackline Inc | < 0.1% | 72,910 | 4.4M USD | −77.1% reduced | Q2 2024 3 quarters |
| DECK Deckers Brands | < 0.1% | 21,657 | 4.4M USD | −96.7% reduced | Q3 2024 2 quarters |
| Liberty Broadband Corp | < 0.1% | 58,020 | 4.3M USD | −80.3% reduced | Q4 2022 9 quarters |
| Dianthus Therapeutics Inc | < 0.1% | 193,600 | 4.2M USD | −55.8% reduced | Q1 2024 4 quarters |
| Quidelortho Corp | < 0.1% | 93,915 | 4.2M USD | −87.5% reduced | Q3 2024 2 quarters |
| ROST Ross Stores | < 0.1% | 27,278 | 4.1M USD | −97.1% reduced | Q1 2024 4 quarters |
| CPAY Corpay | < 0.1% | 12,029 | 4.1M USD | −32.9% reduced | Q3 2024 2 quarters |
| Sutro Biopharma Inc | < 0.1% | 2,197,538 | 4.0M USD | −26.7% reduced | Q2 2023 7 quarters |
| Eastgroup Pptys Inc | < 0.1% | 24,909 | 4.0M USD | −30.0% reduced | Q3 2024 2 quarters |
| Fidelity National Financial | < 0.1% | 69,156 | 3.9M USD | −62.6% reduced | Q3 2024 2 quarters |
| Foot Locker Inc | < 0.1% | 161,603 | 3.5M USD | −70.6% reduced | Q2 2024 3 quarters |
| CME CME Group | < 0.1% | 15,000 | 3.5M USD | −84.7% reduced | Q2 2014 or earlier 43 quarters |
| Urogen Pharma Ltd | < 0.1% | 317,114 | 3.4M USD | −79.0% reduced | Q3 2023 6 quarters |
| Evolent Health Inc | < 0.1% | 281,144 | 3.2M USD | −81.2% reduced | Q3 2023 6 quarters |
| Banco Santander S.a. | < 0.1% | 650,884 | 3.0M USD | −6.0% reduced | Q3 2024 2 quarters |
| Ovintiv Inc | < 0.1% | 70,000 | 2.8M USD | −41.6% reduced | Q3 2023 6 quarters |
| Cryoport Inc | < 0.1% | 352,680 | 2.7M USD | −16.0% reduced | Q3 2024 2 quarters |
| Fulgent Genetics Inc | < 0.1% | 143,613 | 2.7M USD | −46.7% reduced | Q3 2024 2 quarters |
| First Watch Restaurant Group | < 0.1% | 140,098 | 2.6M USD | −53.7% reduced | Q3 2024 2 quarters |
| Helix Energy Solutions Grp I | < 0.1% | 277,835 | 2.6M USD | −82.1% reduced | Q3 2022 10 quarters |
| Grindr Inc | < 0.1% | 142,879 | 2.5M USD | −20.5% reduced | Q2 2024 3 quarters |
| Toro Co | < 0.1% | 31,315 | 2.5M USD | −90.5% reduced | Q1 2024 4 quarters |
| Gds HLDGS Ltd | < 0.1% | 100,554 | 2.4M USD | −34.3% reduced | Q1 2023 8 quarters |
| Hf Sinclair Corp | < 0.1% | 67,636 | 2.4M USD | −95.1% reduced | Q2 2024 3 quarters |
| Grupo Financiero Galicia S.a | < 0.1% | 35,184 | 2.2M USD | −62.6% reduced | Q3 2024 2 quarters |
| Nova Ltd | < 0.1% | 10,889 | 2.1M USD | −55.2% reduced | Q2 2023 7 quarters |
| Kite Rlty Group TR | < 0.1% | 83,462 | 2.1M USD | −0.8% reduced | Q3 2023 6 quarters |
| CASY Casey's | < 0.1% | 5,271 | 2.1M USD | −87.1% reduced | Q2 2024 3 quarters |
| Bumble Inc | < 0.1% | 247,227 | 2.0M USD | −78.9% reduced | Q2 2024 3 quarters |
| Arcosa Inc | < 0.1% | 20,033 | 1.9M USD | −78.3% reduced | Q2 2024 3 quarters |
| VICI Vici Properties | < 0.1% | 63,432 | 1.9M USD | −31.8% reduced | Q3 2024 2 quarters |
| BNY BNY Mellon | < 0.1% | 24,036 | 1.8M USD | −85.8% reduced | Q2 2024 3 quarters |
| Goodrx HLDGS Inc | < 0.1% | 381,903 | 1.8M USD | −76.5% reduced | Q3 2024 2 quarters |
| Caribou Biosciences Inc | < 0.1% | 1,024,989 | 1.6M USD | −51.9% reduced | Q4 2022 9 quarters |
| Vestis Corporation | < 0.1% | 105,683 | 1.6M USD | −58.6% reduced | Q2 2024 3 quarters |
| Ttm Technologies Inc | < 0.1% | 63,943 | 1.6M USD | −82.0% reduced | Q3 2024 2 quarters |
| Health Catalyst Inc | < 0.1% | 215,160 | 1.5M USD | −58.4% reduced | Q1 2022 12 quarters |
| Curevac N V | < 0.1% | 440,509 | 1.5M USD | −43.5% reduced | Q2 2024 3 quarters |
| Mizuho Financial Group Inc | < 0.1% | 303,800 | 1.5M USD | −46.8% reduced | Q1 2024 4 quarters |
| Douyu Intl HLDGS Ltd | < 0.1% | 126,636 | 1.4M USD | −22.2% reduced | Q3 2024 2 quarters |
| Ww Intl Inc | < 0.1% | 1,050,295 | 1.3M USD | −4.8% reduced | Q2 2024 3 quarters |
| Sportradar Group AG | < 0.1% | 76,579 | 1.3M USD | −20.6% reduced | Q2 2024 3 quarters |
| Cargurus Inc | < 0.1% | 35,433 | 1.3M USD | −5.5% reduced | Q3 2023 6 quarters |
| Technipfmc PLC | < 0.1% | 43,718 | 1.3M USD | −98.2% reduced | Q2 2023 7 quarters |
| Ameresco Inc | < 0.1% | 50,746 | 1.2M USD | −83.3% reduced | Q2 2024 3 quarters |
| Mgp Ingredients Inc New | < 0.1% | 26,300 | 1.0M USD | −40.5% reduced | Q3 2024 2 quarters |
| Rush Street Interactive Inc | < 0.1% | 72,600 | 996.1K USD | −28.2% reduced | Q1 2024 4 quarters |
| Olin Corp | < 0.1% | 29,444 | 995.2K USD | −92.3% reduced | Q1 2021 16 quarters |
| SS&C Technologies HLDGS Inc | < 0.1% | 12,896 | 977.3K USD | −97.8% reduced | Q4 2023 5 quarters |
| Stride Inc | < 0.1% | 9,251 | 961.4K USD | −95.6% reduced | Q1 2023 8 quarters |
| Credit Accep Corp Mich | < 0.1% | 1,934 | 907.8K USD | −78.3% reduced | Q3 2024 2 quarters |
| KIM Kimco Realty | < 0.1% | 38,646 | 905.5K USD | −16.5% reduced | Q3 2024 2 quarters |
| Boise Cascade Co Del | < 0.1% | 7,506 | 892.1K USD | −86.2% reduced | Q3 2024 2 quarters |
| Levi Strauss & Co New | < 0.1% | 49,957 | 864.3K USD | −80.4% reduced | Q2 2024 3 quarters |
| Enova Intl Inc | < 0.1% | 9,000 | 862.9K USD | −26.8% reduced | Q3 2024 2 quarters |
| Disc Medicine Inc | < 0.1% | 13,444 | 852.4K USD | −98.2% reduced | Q2 2024 3 quarters |
| Semrush HLDGS Inc | < 0.1% | 71,315 | 847.2K USD | −35.7% reduced | Q2 2024 3 quarters |
| Sibanye Stillwater Ltd | < 0.1% | 245,100 | 808.8K USD | −57.4% reduced | Q3 2024 2 quarters |
| Ardagh Metal Packaging S A | < 0.1% | 267,776 | 806.0K USD | −5.8% reduced | Q4 2023 5 quarters |
| Wisdomtree Inc | < 0.1% | 74,500 | 782.3K USD | −61.4% reduced | Q3 2024 2 quarters |
| Clover Health Investments Co | < 0.1% | 237,200 | 747.2K USD | −9.0% reduced | Q3 2024 2 quarters |
| Old Natl Bancorp Ind | < 0.1% | 33,926 | 736.4K USD | −94.8% reduced | Q1 2024 4 quarters |
| Icl Group Ltd | < 0.1% | 146,968 | 726.0K USD | −52.6% reduced | Q3 2024 2 quarters |
| Payoneer Global Inc | < 0.1% | 71,641 | 719.3K USD | −48.6% reduced | Q1 2023 8 quarters |
| Forestar Group Inc | < 0.1% | 27,602 | 715.4K USD | −11.8% reduced | Q3 2024 2 quarters |
| Grupo Supervielle S.a. | < 0.1% | 47,200 | 713.2K USD | −66.3% reduced | Q3 2024 2 quarters |
| C4 Therapeutics Inc | < 0.1% | 196,466 | 707.3K USD | −83.7% reduced | Q1 2023 8 quarters |
| Uwm Holdings Corporation | < 0.1% | 118,515 | 695.7K USD | −5.2% reduced | Q3 2024 2 quarters |
| Travel Plus Leisure Co | < 0.1% | 13,615 | 686.9K USD | −91.7% reduced | Q2 2024 3 quarters |
| B & G Foods Inc New | < 0.1% | 98,240 | 676.9K USD | −9.3% reduced | Q3 2024 2 quarters |
| Gerdau SA | < 0.1% | 233,600 | 672.8K USD | −75.1% reduced | Q3 2024 2 quarters |
| Abivax SA | < 0.1% | 91,300 | 668.3K USD | −83.2% reduced | Q4 2023 5 quarters |
| Qifu Technology Inc | < 0.1% | 17,300 | 664.0K USD | −89.5% reduced | Q3 2024 2 quarters |
| Afya Ltd | < 0.1% | 41,465 | 658.5K USD | −15.9% reduced | Q3 2024 2 quarters |
| Leonardo Drs Inc | < 0.1% | 19,900 | 643.0K USD | −66.0% reduced | Q3 2024 2 quarters |
| Greenbrier Cos Inc | < 0.1% | 10,184 | 621.1K USD | −18.8% reduced | Q3 2024 2 quarters |
| Nuvation Bio Inc | < 0.1% | 226,824 | 603.4K USD | −18.0% reduced | Q3 2024 2 quarters |
| Paragon 28 Inc | < 0.1% | 58,055 | 599.7K USD | −77.5% reduced | Q4 2023 5 quarters |
| Wayfair Inc | < 0.1% | 13,200 | 585.0K USD | −83.4% reduced | Q3 2022 10 quarters |
| Nomura HLDGS Inc | < 0.1% | 99,400 | 575.5K USD | −27.7% reduced | Q3 2024 2 quarters |
| Comerica Inc | < 0.1% | 9,278 | 573.8K USD | −90.9% reduced | Q3 2024 2 quarters |
| Lancaster Colony Corp | < 0.1% | 3,300 | 571.4K USD | −69.4% reduced | Q1 2023 8 quarters |
| Sonic Automotive Inc | < 0.1% | 8,954 | 567.2K USD | −21.5% reduced | Q1 2024 4 quarters |
| Cra Intl Inc | < 0.1% | 2,608 | 488.3K USD | −29.5% reduced | Q3 2024 2 quarters |
| Netstreit Corp | < 0.1% | 32,672 | 462.3K USD | −32.8% reduced | Q1 2024 4 quarters |
| Elbit Sys Ltd | < 0.1% | 1,791 | 462.3K USD | −73.7% reduced | Q4 2023 5 quarters |
| Preferred Bk Los Angeles Ca | < 0.1% | 5,300 | 457.8K USD | −17.2% reduced | Q4 2023 5 quarters |
| Marex Group PLC | < 0.1% | 14,600 | 455.1K USD | −17.0% reduced | Q2 2024 3 quarters |
| Amalgamated Financial Corp | < 0.1% | 13,500 | 451.8K USD | −36.7% reduced | Q1 2024 4 quarters |
| Criteo S A | < 0.1% | 11,100 | 439.1K USD | −57.0% reduced | Q4 2023 5 quarters |
| Ftai Aviation Ltd | < 0.1% | 3,000 | 432.1K USD | −83.6% reduced | Q1 2023 8 quarters |
| Vigil Neuroscience Inc | < 0.1% | 250,000 | 425.0K USD | −84.4% reduced | Q2 2024 3 quarters |
| Coupang Inc | < 0.1% | 18,600 | 408.8K USD | −98.4% reduced | Q2 2024 3 quarters |
| Select Sector SPDR TR | < 0.1% | 1,664 | 373.3K USD | −80.7% reduced | Q1 2023 8 quarters |
| Pros Holdings Inc | < 0.1% | 16,400 | 360.1K USD | −48.2% reduced | Q3 2023 6 quarters |
| Alpha Metallurgical Resour I | < 0.1% | 1,767 | 353.6K USD | −90.4% reduced | Q3 2024 2 quarters |
| City Hldg Co | < 0.1% | 2,883 | 341.6K USD | −0.6% reduced | Q3 2023 6 quarters |
| Amphastar Pharmaceuticals In | < 0.1% | 9,200 | 341.6K USD | −76.3% reduced | Q1 2024 4 quarters |
| Global Ship Lease Inc New | < 0.1% | 15,600 | 340.5K USD | −41.6% reduced | Q3 2024 2 quarters |
| Unilever PLC | < 0.1% | 6,000 | 340.2K USD | −71.4% reduced | Q3 2024 2 quarters |
| Nerdwallet Inc | < 0.1% | 24,300 | 323.2K USD | −65.3% reduced | Q3 2024 2 quarters |
| Idt Corp | < 0.1% | 6,726 | 319.6K USD | −49.8% reduced | Q1 2024 4 quarters |
| Hovnanian Enterprises Inc | < 0.1% | 2,326 | 311.2K USD | −30.8% reduced | Q3 2024 2 quarters |
| Onespaworld Holdings Limited | < 0.1% | 15,231 | 303.1K USD | −15.3% reduced | Q4 2023 5 quarters |
| Constellium SE | < 0.1% | 29,500 | 303.0K USD | −22.6% reduced | Q2 2024 3 quarters |
| Mercer Intl Inc | < 0.1% | 44,700 | 290.6K USD | −13.9% reduced | Q2 2024 3 quarters |
| Mission Produce Inc | < 0.1% | 19,946 | 286.6K USD | −5.4% reduced | Q2 2024 3 quarters |
| Coastal Finl Corp Wa | < 0.1% | 3,300 | 280.2K USD | −19.2% reduced | Q3 2024 2 quarters |
| Bancolombia S A | < 0.1% | 8,400 | 264.7K USD | −48.5% reduced | Q2 2024 3 quarters |
| Intercontinental Hotels Grou | < 0.1% | 2,102 | 262.6K USD | −48.0% reduced | Q1 2024 4 quarters |
| Nlight Inc | < 0.1% | 24,400 | 256.0K USD | −57.8% reduced | Q4 2022 9 quarters |
| Copt Defense Properties | < 0.1% | 7,000 | 216.7K USD | −71.2% reduced | Q4 2023 5 quarters |
| Korn Ferry | < 0.1% | 3,139 | 211.7K USD | −74.7% reduced | Q2 2024 3 quarters |
| Sunopta Inc | < 0.1% | 26,531 | 204.3K USD | −18.1% reduced | Q2 2024 3 quarters |
| NWS News Corp (Class B) | < 0.1% | 6,640 | 202.0K USD | −78.5% reduced | Q3 2024 2 quarters |
| Hain Celestial Group Inc | < 0.1% | 32,606 | 200.5K USD | −80.3% reduced | Q1 2023 8 quarters |
| DDOG Datadog | < 0.1% | 1,400 | 200.0K USD | −99.0% reduced | Q3 2024 2 quarters |
| Community Healthcare TR Inc | < 0.1% | 9,785 | 188.0K USD | −10.2% reduced | Q3 2024 2 quarters |
| Cellebrite Di Ltd | < 0.1% | 8,461 | 186.4K USD | −91.4% reduced | Q4 2023 5 quarters |
| Customers Bancorp Inc | < 0.1% | 3,800 | 185.0K USD | −20.8% reduced | Q3 2024 2 quarters |
| Leslies Inc | < 0.1% | 79,500 | 177.3K USD | −85.2% reduced | Q3 2024 2 quarters |
| Community TR Bancorp Inc | < 0.1% | 3,200 | 169.7K USD | −43.6% reduced | Q3 2024 2 quarters |
| Montauk Renewables Inc | < 0.1% | 41,529 | 165.3K USD | −68.6% reduced | Q1 2023 8 quarters |
| Willdan Group Inc | < 0.1% | 4,300 | 163.8K USD | −47.0% reduced | Q2 2024 3 quarters |
| Gray Television Inc | < 0.1% | 43,520 | 137.1K USD | −49.3% reduced | Q3 2024 2 quarters |
| Companhia Siderurgica Nacion | < 0.1% | 94,289 | 135.8K USD | −68.7% reduced | Q2 2024 3 quarters |
| Netgear Inc | < 0.1% | 4,782 | 133.3K USD | −62.4% reduced | Q3 2024 2 quarters |
| Axogen Inc | < 0.1% | 8,000 | 131.8K USD | −53.2% reduced | Q3 2024 2 quarters |
| Taboola.com Ltd | < 0.1% | 35,200 | 128.5K USD | −59.4% reduced | Q2 2024 3 quarters |
| Eagle Bancorp Inc Md | < 0.1% | 4,100 | 106.7K USD | −62.0% reduced | Q2 2024 3 quarters |
| Banco Macro SA | < 0.1% | 1,100 | 106.4K USD | −91.5% reduced | Q3 2024 2 quarters |
| Liberty Global Ltd | < 0.1% | 8,000 | 105.1K USD | −14.2% reduced | Q2 2024 3 quarters |
| Select Sector SPDR TR | < 0.1% | 607 | 83.5K USD | −95.4% reduced | Q3 2024 2 quarters |
| Genco Shipping & Trading Ltd | < 0.1% | 5,578 | 77.8K USD | −78.1% reduced | Q4 2023 5 quarters |
| Vimeo Inc | < 0.1% | 11,700 | 74.9K USD | −79.0% reduced | Q3 2024 2 quarters |
| Olo Inc | < 0.1% | 9,709 | 74.6K USD | −35.1% reduced | Q3 2024 2 quarters |
| Tim S A | < 0.1% | 6,000 | 70.6K USD | −92.8% reduced | Q4 2023 5 quarters |
| Centerspace | < 0.1% | 1,063 | 70.3K USD | −84.4% reduced | Q3 2024 2 quarters |
| Peapack-Gladstone Finl Corp | < 0.1% | 2,107 | 67.5K USD | −12.2% reduced | Q2 2024 3 quarters |
| Enterprise Finl Svcs Corp | < 0.1% | 1,119 | 63.1K USD | −82.6% reduced | Q3 2023 6 quarters |
| Hamilton Insurance Group Ltd | < 0.1% | 3,278 | 62.4K USD | −78.8% reduced | Q4 2023 5 quarters |
| Northfield Bancorp Inc Del | < 0.1% | 3,500 | 40.7K USD | −30.7% reduced | Q2 2024 3 quarters |
| Keros Therapeutics Inc | < 0.1% | 1,592 | 25.2K USD | −99.8% reduced | Q3 2022 10 quarters |
| Y-Mabs Therapeutics Inc | < 0.1% | 550 | 4.3K USD | −99.4% reduced | Q1 2024 4 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Plus 804 option positions, value of the underlying shares as reported 8.9B USD – not included in the weights.
The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.
- SPDR S&P 500 ETF TR Call 1.7B USD
- SPDR S&P 500 ETF TR Put 1.7B USD
- Ishares TR Put 239.7M USD
- Invesco QQQ TR Put 162.3M USD
- Apple Inc. Call 118.6M USD
- Hershey Company (The) Call 70.8M USD
- Novo Nordisk (ADR) Put 68.8M USD
- Select Sector SPDR TR Put 65.7M USD
- Ishares TR Call 61.9M USD
- Apple Inc. Put 54.9M USD
Plus 44 positions in convertible bonds and bonds worth 765.0M USD as reported – not included in the weights.
Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.
- Axon Enterprise Inc principal 20.0M USD 52.2M USD
- Microstrategy Inc principal 23.0M USD 47.7M USD
- Bridgebio Pharma Inc principal 37.5M USD 39.3M USD
- Lumentum HLDGS Inc principal 33.5M USD 37.0M USD
- Cytokinetics Inc principal 29.7M USD 35.5M USD
- Ascendis Pharma A/S principal 31.5M USD 34.7M USD
- Ncl Corp Ltd principal 32.6M USD 34.2M USD
- Mirum Pharmaceuticals Inc principal 18.9M USD 28.8M USD
- Ncl Corp Ltd principal 20.0M USD 28.7M USD
- Insulet Corp principal 22.5M USD 28.5M USD
Breakdown by sector
- Technology 18.7%
- Consumer Discretionary 6.4%
- Health Care 6.0%
- Industrials 5.4%
- Financials 4.1%
- Utilities 3.5%
- Communication Services 3.5%
- Consumer Staples 3.5%
- Energy 2.6%
- Materials 1.8%
- Real Estate 1.2%
- not in our coverage 43.1%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors